Dr Blanchard is a full Professor of radiation oncology at Gustave Roussy Cancer Center, France. He has developed a clinical expertise in the field of Head and Neck radiotherapy, Genitourinary radiotherapy and brachytherapy as well as proton therapy and quality of life studies. In parallel to his medical training, he performed a PhD in Public Health on Biostatistics and individual patient data meta-analyses. He is currently the clinical coordinator of the Head and Neck meta-analyses performed at Gustave Roussy (> 200 trials, 5 individual patients meta-analyses). He is very active within the internationally recognized head and neck research groups GORTEC (head and neck oncology) and GETUG (urologic oncology). He is the primary investigator of international phase III trials on prostate cancers (high-risk localized, oligometastatic) and randomized trials of head and neck cancers, specifically for HPV-induced cancers. Dr Blanchard also serves as faculty for different courses organized at Gustave Roussy and is currently responsible for a national teaching course on head and neck radiotherapy. He has published more than 200 articles in peer-reviewed journals and is a frequent reviewer for major journals, including The Lancet and the New England Journal of Medicine. He is currently an adjunct Professor at the UT MD Anderson Cancer Center, after having spent two years there as a visiting Faculty, and the Editor-in-Chief of Radiotherapy & Oncology (https://www.thegreenjournal.com/) since May 2024. He has been appointed in 2019 as the Director of Gustave Roussy’s teaching body, the School of Cancer Sciences, .
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none